Outcomes of Total Thyroidectomy with Therapeutic Central and Lateral Neck Dissection with a Single Dose of Radioiodine in the Treatment of Regionally Advanced Papillary Thyroid Cancer and Effects on Serum Thyroglobulin
- 3 January 2014
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (5) , 1647-1652
Abstract
Achieving an undetectable serum thyroglobulin (Tg) level (<1.0 ng/mL) after surgical and radioiodine treatment for papillary thyroid cancer (PTC) is associated with low recurrence rates and has been termed biochemical remission. This study aimed to determine the effectiveness of total thyroidectomy with therapeutic central and lateral neck dissection for regionally advanced (T1–4bN1bM0) PTC with regard to posttreatment Tg levels. This is a single-institution retrospective cohort study of patients with regionally advanced PTC initially treated with total thyroidectomy and therapeutic levels 2–7 neck dissection from 2002 to 2012. Pathologic findings, complications, serum Tg levels, and outcomes were analyzed. Sixty-one patients were initially treated with total thyroidectomy and therapeutic central and lateral neck dissection for PTC involving the lateral cervical nodes (N1b). The median number of lymph nodes excised and positive was 27 (range 5–112) and 9 (range 1–67), respectively. Extranodal extension occurred in 48 %. Radioiodine was administered after surgery with a median total dose of 150 mCi (range 30–244 mCi). Recurrent or persistent cervical disease occurred in 8 (13 %) and 3 (5 %) patients, respectively, and required additional radioiodine treatment in 2 and reoperative neck dissection in 10. Three patients developed new distant metastasis, and 1 died during the median follow-up of 20 months (range 1–109 months). Undetectable unstimulated Tg (<1.0 ng/mL) without clinically detectable recurrence was experienced in 68 % of patients with initial treatment. Biochemical remission can be experienced in most patients presenting with regionally advanced PTC with total thyroidectomy and compartment based therapeutic neck dissection followed by a single dose of radioiodine.Keywords
This publication has 18 references indexed in Scilit:
- Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer— is there a need for radioactive iodine therapy?Surgery, 2012
- Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancerSurgery, 2010
- Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid CancerThyroid®, 2009
- Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?Surgery, 2009
- The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinomaSurgery, 2008
- Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinomaSurgery, 2008
- Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma?Head & Neck, 2007
- Clinically significant prognostic factors for differentiated thyroid carcinomaCancer, 2005
- Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysisClinical Endocrinology, 2004
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994